HROW Q4 2018 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q4 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$11M+55.2% YoY

Gross Profit

$7M64.0% margin

Operating Income

-$2M-19.0% margin

Net Income

$18M159.3% margin

EPS (Diluted)

$1.32

QoQ Revenue Growth

+6.0%

Cash Flow

Operating Cash Flow

-$36,000

Free Cash Flow

-$888,000

Stock-Based Comp.

$686,000

Balance Sheet

Total Assets

$49M

Total Liabilities

$25M

Stockholders' Equity

$25M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$7M	+55.2%
Gross Profit	$7M	$4M	+87.7%
Operating Income	-$2M	-$2M	-0.6%
Net Income	$18M	-$3M	+754.3%